At Diligent we connect clinical research sponsors, CROs, technology and service providers - quickly, efficiently and at very low risk. This can reduce the time taken to start clinical trials by up to 70 days.
The cloud-based Diligent Qualification Platform holds comprehensive Request For Information (RFI) details for industry suppliers around the world, as well as Vendor Qualification Assessments (VQAs) audited against latest industry standards.
This makes it easy for trial sponsors to identify and qualify relevant potential suppliers - much more quickly than by using traditional methods. It's also a great timesaver for industry suppliers as it cuts the number of RFIs to be completed and VQAs to host, while providers maintain 100% control over who sees their company information.
With the Diligent Qualification Platform, industry vendors are more visible and easily accessible to organizations actively searching for partners to conduct clinical research. Meanwhile trial sponsors can take advantage of the most recent technologies on the market with an objective selection process based on verified and up to date supplier details.
The cloud-based Diligent Qualification Platform holds comprehensive Request For Information (RFI) details for industry suppliers around the world, as well as Vendor Qualification Assessments (VQAs) audited against latest industry standards.
This makes it easy for trial sponsors to identify and qualify relevant potential suppliers - much more quickly than by using traditional methods. It's also a great timesaver for industry suppliers as it cuts the number of RFIs to be completed and VQAs to host, while providers maintain 100% control over who sees their company information.
With the Diligent Qualification Platform, industry vendors are more visible and easily accessible to organizations actively searching for partners to conduct clinical research. Meanwhile trial sponsors can take advantage of the most recent technologies on the market with an objective selection process based on verified and up to date supplier details.
Location: United States, Pennsylvania, Philadelphia
Employees: 11-50
Total raised: $8.27M
Founded date: 2018
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 15.05.2023 | Series A | $8.27M | - |
Mentions in press and media 4
| Date | Title | Description |
| 15.05.2023 | Diligent Pharma Closes $8.27M Series A Financing | Diligent Pharma, a Princeton, NJ-based private vendor qualification and risk management organization, raised $8.27M in Series A funding. The round was led by FCA Venture Partners with participation from PJC, and GenHenn Capital. The company... |
| 15.05.2023 | Diligent Pharma Completes $8.27 Million Series A | PRINCETON, NJ, Diligent Pharma announced the closing of an $8.27 Million Series A financing round led by FCA Venture Partners. >> Click here for more funding data on Diligent Pharma >> To export Diligent Pharma funding data ... |
| 30.09.2022 | Diligent Pharma launches Vendor Qualification Assessment (VQA) Report Library for QA Teams at Clinical Trial Sponsors | Download VQA Reports easily Diligent Pharma Leads the Industry in Driving a More Efficient Process for Vendor Qualification The VQA report library is an example of how the Diligent Qualification Platform is addressing the inefficiencies and... |
| - | Diligent Pharma | “Simplify and streamline selection and qualification of GCP clinical trial service providers with our online platform” |